UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000007648 |
|---|---|
| Receipt number | R000009019 |
| Scientific Title | A phase II study of neoadjuvant epirubicin/cyclophosphamide (EC) followed by weekly nanoparticle albumin-bound paclitaxel with or without trastuzumab for node-positive breast cancer |
| Date of disclosure of the study information | 2012/04/02 |
| Last modified on | 2016/05/11 10:13:04 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/04/02 23:16:27 | ||
| 2 | Update | 2013/04/03 12:18:39 | Recruitment status |
|
| 3 | Update | 2013/05/23 13:07:30 | Institute Email1 |
|
| 4 | Update | 2016/05/11 10:10:42 | Basic design No. of arms Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 |
|
| 5 | Update | 2016/05/11 10:13:04 | Email Name of primary person or sponsor Institute Organization Organization |
